{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:20:41Z","timestamp":1788495641817,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.brainres.2025.149870","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:10:01Z","timestamp":1755493801000},"page":"149870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["POU2F1 facilitates the malignant phenotypes and aerobic glycolysis of pituitary adenoma by activating LDHA transcription"],"prefix":"10.1016","volume":"1866","author":[{"given":"Huanhuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lige","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2025.149870_b0005","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1038\/s41598-017-04366-5","article-title":"Lactate dehydrogenase a promotes the invasion and proliferation of pituitary adenoma","volume":"7","author":"An","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2025.149870_b0010","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1007\/s11064-023-04011-w","article-title":"POU2F1\/DNMT3a pathway participates in neuropathic pain by hypermethylation-mediated LRFN4 downregulation following oxaliplatin treatment","volume":"48","author":"Gu","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2025.149870_b0015","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.2147\/OTT.S141476","article-title":"CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma","volume":"10","author":"Huang","year":"2017","journal-title":"Onco Targets Ther"},{"issue":"5","key":"10.1016\/j.brainres.2025.149870_b0020","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/endrev\/bnad014","article-title":"Current and future advances in surgical therapy for pituitary adenoma","volume":"44","author":"Khan","year":"2023","journal-title":"Endocrine Rev."},{"key":"10.1016\/j.brainres.2025.149870_b0025","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41388-021-02148-y","article-title":"The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity","volume":"41","author":"Lin","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.brainres.2025.149870_b0030","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocrine Rev."},{"key":"10.1016\/j.brainres.2025.149870_b0035","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4155\/fmc-2017-0082","article-title":"When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic?","volume":"9","author":"Rani","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.brainres.2025.149870_b0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2024.07.002","article-title":"Thematic issue 'tumor glycolysis'","volume":"104\u2013105","author":"Rani","year":"2024","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.brainres.2025.149870_b0045","article-title":"Intervention on lactate in cancer: a promising approach for the development of cancer therapeutics","volume":"5","author":"Sharma","year":"2022","journal-title":"Adv. Cancer Bio. - Metastasis"},{"key":"10.1016\/j.brainres.2025.149870_b0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/carcin\/bgab042","article-title":"On the potential origin and characteristics of cancer stem cells","volume":"42","author":"Trosko","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.brainres.2025.149870_b0060","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.7150\/ijbs.91206","article-title":"Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination","volume":"20","author":"Xia","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.brainres.2025.149870_b0065","article-title":"POU2F1 inhibits miR-29b1\/a cluster-mediated suppression of PIK3R1 and PIK3R3 expression to regulate gastric cancer cell invasion and migration","author":"Xiao","year":"2024","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.brainres.2025.149870_b0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/path.4515","article-title":"ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling","volume":"236","author":"Xu","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.brainres.2025.149870_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-024-00372-0","article-title":"Phosphatidylinositol promoted the proliferation and invasion of pituitary adenoma cells by regulating POU1F1 expression","volume":"13","author":"Xu","year":"2025","journal-title":"Cancer Metab."},{"key":"10.1016\/j.brainres.2025.149870_b0080","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.7150\/thno.53749","article-title":"Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325004317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325004317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:23:42Z","timestamp":1780115022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325004317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":15,"alternative-id":["S0006899325004317"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149870","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"POU2F1 facilitates the malignant phenotypes and aerobic glycolysis of pituitary adenoma by activating LDHA transcription","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149870"}}